RPS6 and melanoma: Single-cell analysis reveals that NF1LoF (neurofibromatosis 1 loss of function) melanoma cells’ response to drugs is significantly associated with the inhibition of both Ki-67 (a marker of cell proliferation) and p-S6 (phosphorylation of ribosomal S6 protein, an effector molecule of the mTOR signaling pathway).